Compare · BFLY vs PHG
BFLY vs PHG
Side-by-side comparison of Butterfly Network Inc. (BFLY) and Koninklijke Philips N.V. NY Registry Shares (PHG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BFLY and PHG operate in Medical Electronics (Health Care), so they compete in similar markets.
- PHG is the larger of the two at $24.89B, about 17.6x BFLY ($1.41B).
- Over the past year, BFLY is up 131.8% and PHG is up 2.2% - BFLY leads by 129.6 points.
- BFLY has been more active in the news (9 items in the past 4 weeks vs 3 for PHG).
- PHG has more recent analyst coverage (22 ratings vs 8 for BFLY).
- Company
- Butterfly Network Inc.
- Koninklijke Philips N.V. NY Registry Shares
- Price
- -
- -
- Market cap
- $1.41B
- $24.89B
- 1M return
- +31.78%
- -4.12%
- 1Y return
- +131.83%
- +2.21%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NYSE
- NYSE
- IPO
- 2020
- News (4w)
- 9
- 3
- Recent ratings
- 8
- 22
Butterfly Network Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
Koninklijke Philips N.V. NY Registry Shares
Koninklijke Philips N.V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also offers monitoring and analytics solutions; sleep and respiratory care solutions; emergency care and resuscitation, and patient management solutions; data, analytics, and actionable workflow solutions; and connected care informatics solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; male grooming and beauty products and solutions; and kitchen appliances, home care, and garment care products, as well as coffee machines. Koninklijke Philips N.V. has a partnership with openDoctor to deliver an integrated radiology patient engagement platform that leverages openDoctor's real-time online appointment scheduling services as part of its patient management solution; and a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Latest BFLY
- Chief Business Officer Cashman Steve sold $724,166 worth of shares (147,518 units at $4.91), decreasing direct ownership by 7% to 2,029,868 units (SEC Form 4) (tax liability)
- SEC Form 10-Q filed by Butterfly Network Inc.
- Butterfly Network Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Butterfly Network Reports First Quarter 2026 Financial Results
- SEC Form DEFA14A filed by Butterfly Network Inc.
- SEC Form DEF 14A filed by Butterfly Network Inc.
- Butterfly Network Appoints Arun Nagdev, MD as Chief Medical Officer – POCUS
- SEC Form 4 filed by Cashman Steve
- Butterfly Network to Report First Quarter 2026 Financial Results on April 30, 2026
- Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women's Health
Latest PHG
- Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction
- Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning
- Philips receives FDA 510(k) clearance for Verida, the world's first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications
- SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares
- SEC Form 6-K filed by Koninklijke Philips N.V. NY Registry Shares
- FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair
- Philips launches IntraSight Plus to simplify coronary interventions and advance precision care
- Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant
- Philips convenes the Annual General Meeting of Shareholders 2026
- Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment